{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:34:01Z","timestamp":1787236441800,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,8,25]],"date-time":"2010-08-25T00:00:00Z","timestamp":1282694400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s10875-010-9453-y","type":"journal-article","created":{"date-parts":[[2010,8,24]],"date-time":"2010-08-24T00:56:40Z","timestamp":1282611400000},"page":"872-880","source":"Crossref","is-referenced-by-count":9,"title":["Profile of Autoantibodies Against Phosphorylcholine and Cross-reactivity to Oxidation-Specific Neoantigens in Selective IgA Deficiency With or Without Autoimmune Diseases"],"prefix":"10.1007","volume":"30","author":[{"given":"Ana Elisa","family":"Fusaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Fahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine Cristina","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyro Alves","family":"de Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina M. A.","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Carneiro-Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto J. S.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Notomi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,25]]},"reference":[{"key":"9453_CR1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10875-007-9103-1","volume":"27","author":"JM Boyle","year":"2007","unstructured":"Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol. 2007;27:497\u2013502.","journal-title":"J Clin Immunol"},{"key":"9453_CR2","first-page":"213","volume":"17","author":"MM Carneiro-Sampaio","year":"1989","unstructured":"Carneiro-Sampaio MM, Carbonare SB, Rozentraub RB, de Araujo MN, Ribeiro MA, Porto MH. Frequency of selective IgA deficiency among Brazilian blood donors and healthy pregnant women. Allergol Immunopathol. 1989;17:213\u20136.","journal-title":"Allergol Immunopathol"},{"key":"9453_CR3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/clim.1999.4799","volume":"93","author":"ME Conley","year":"1999","unstructured":"Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93:190\u20137.","journal-title":"Clin Immunol"},{"key":"9453_CR4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1023\/A:1012241117984","volume":"21","author":"C Cunningham-Rundles","year":"2001","unstructured":"Cunningham-Rundles C. Physiology of IgA and IgA deficiency. J Clin Immunol. 2001;21:303\u20139.","journal-title":"J Clin Immunol"},{"key":"9453_CR5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1067\/mai.2002.122466","volume":"109","author":"M Ballow","year":"2002","unstructured":"Ballow M. Primary immunodeficiency disorders: antibody deficiency. J Allergy Clin Immunol. 2002;109:581\u201391.","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 1","key":"9453_CR6","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1007\/s10875-007-9163-2","volume":"28","author":"CM Jacob","year":"2008","unstructured":"Jacob CM, Pastorino AC, Fahl K, Carneiro-Sampaio M, Monteiro RC. Autoimmunity in IgA deficiency: revisiting the role of IgA as a silent housekeeper. J Clin Immunol. 2008;28 Suppl 1:S56\u201361.","journal-title":"J Clin Immunol"},{"key":"9453_CR7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000135694","volume":"147","author":"A Aghamohammadi","year":"2008","unstructured":"Aghamohammadi A, Mohammadi J, Parvaneh N, Rezaei N, Moin M, Espanol T, et al. Progression of selective IgA deficiency to common variable immunodeficiency. Int Arch Allergy Immunol. 2008;147:87\u201392.","journal-title":"Int Arch Allergy Immunol"},{"key":"9453_CR8","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S1568-9972(03)00052-1","volume":"2","author":"A Etzioni","year":"2003","unstructured":"Etzioni A. Immune deficiency and autoimmunity. Autoimmun Rev. 2003;2:364\u20139.","journal-title":"Autoimmun Rev"},{"key":"9453_CR9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1054\/blre.2001.0185","volume":"16","author":"C Cunningham-Rundles","year":"2002","unstructured":"Cunningham-Rundles C. Hematologic complications of primary immune deficiencies. Blood Rev. 2002;16:61\u20134.","journal-title":"Blood Rev"},{"key":"9453_CR10","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/0961203307077543","volume":"16","author":"JT Cassidy","year":"2007","unstructured":"Cassidy JT, Kitson RK, Selby CL. Selective IgA deficiency in children and adults with systemic lupus erythematosus. Lupus. 2007;16:647\u201350.","journal-title":"Lupus"},{"key":"9453_CR11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/ard.62.1.83","volume":"62","author":"LJ Badcock","year":"2003","unstructured":"Badcock LJ, Clarke S, Jones PW, Dawes PT, Mattey DL. Abnormal IgA levels in patients with rheumatoid arthritis. Ann Rheum Dis. 2003;62:83\u20134.","journal-title":"Ann Rheum Dis"},{"key":"9453_CR12","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1182\/blood.V99.8.2694","volume":"99","author":"PD Arkwright","year":"2002","unstructured":"Arkwright PD, Abinun M, Cant AJ. Autoimmunity in human primary immunodeficiency diseases. Blood. 2002;99:2694\u2013702.","journal-title":"Blood"},{"issue":"1","key":"9453_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10875-009-9338-0","volume":"30","author":"RC Monteiro","year":"2009","unstructured":"Monteiro RC. Role of IgA and IgA Fc receptors in inflammation. J Clin Immunol. 2009;30(1):1\u20139.","journal-title":"J Clin Immunol"},{"key":"9453_CR14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1365-2370.1998.00098.x","volume":"25","author":"M Gerbase-Delima","year":"1998","unstructured":"Gerbase-Delima M, Pinto LC, Grumach A, Carneiro-Sampaio MM. HLA antigens and haplotypes in IgA-deficient Brazilian paediatric patients. Eur J Immunogenet. 1998;25:281\u20135.","journal-title":"Eur J Immunogenet"},{"key":"9453_CR15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/gene.2008.89","volume":"10","author":"K Haimila","year":"2009","unstructured":"Haimila K, Einarsdottir E, de Kauwe A, Koskinen LL, Pan-Hammarstrom Q, Kaartinen T, et al. The shared CTLA4-ICOS risk locus in celiac disease. IgA deficiency and common variable immunodeficiency. Genes Immun. 2009;10:151\u201361.","journal-title":"Genes Immun"},{"key":"9453_CR16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.clim.2008.11.013","volume":"131","author":"GH Jorgensen","year":"2009","unstructured":"Jorgensen GH, Thorsteinsdottir I, Gudmundsson S, Hammarstrom L, Ludviksson BR. Familial aggregation of IgAD and autoimmunity. Clin Immunol. 2009;131:233\u20139.","journal-title":"Clin Immunol"},{"key":"9453_CR17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/08916930802375711","volume":"42","author":"N Gulez","year":"2009","unstructured":"Gulez N, Karaca NE, Aksu G, Kutukculer N. Increased percentages of autoantibodies in immunoglobulin A-deficient children do not correlate with clinical manifestations. Autoimmunity. 2009;42:74\u20139.","journal-title":"Autoimmunity"},{"key":"9453_CR18","first-page":"154","volume":"12","author":"S Avrameas","year":"1991","unstructured":"Avrameas S. Natural autoantibodies: from \u2018horror autotoxicus\u2019 to \u2018gnothi seauton\u2019. Immunol Today. 1991;12:154\u20139.","journal-title":"Immunol Today"},{"key":"9453_CR19","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/0952-7915(95)80053-0","volume":"7","author":"A Coutinho","year":"1995","unstructured":"Coutinho A, Kazatchkine MD, Avrameas S. Natural autoantibodies. Curr Opin Immunol. 1995;7:812\u20138.","journal-title":"Curr Opin Immunol"},{"key":"9453_CR20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00281-004-0184-0","volume":"26","author":"JF Kearney","year":"2005","unstructured":"Kearney JF. Innate-like B cells. Springer Semin Immunopathol. 2005;26:377\u201383.","journal-title":"Springer Semin Immunopathol"},{"key":"9453_CR21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0167-5699(98)01419-4","volume":"20","author":"W Harnett","year":"1999","unstructured":"Harnett W, Harnett MM. Phosphorylcholine: friend or foe of the immune system? Immunol Today. 1999;20:125\u20139.","journal-title":"Immunol Today"},{"key":"9453_CR22","doi-asserted-by":"crossref","first-page":"13043","DOI":"10.1073\/pnas.192399699","volume":"99","author":"MK Chang","year":"2002","unstructured":"Chang MK, Binder CJ, Torzewski M, Witztum JL. C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids. Proc Natl Acad Sci USA. 2002;99:13043\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9453_CR23","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1172\/JCI8472","volume":"105","author":"PX Shaw","year":"2000","unstructured":"Shaw PX, Horkko S, Chang MK, Curtiss LK, Palinski W, Silverman GJ, et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest. 2000;105:1731\u201340.","journal-title":"J Clin Invest"},{"key":"9453_CR24","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.4049\/jimmunol.170.12.6151","volume":"170","author":"PX Shaw","year":"2003","unstructured":"Shaw PX, Goodyear CS, Chang MK, Witztum JL, Silverman GJ. The autoreactivity of anti-phosphorylcholine antibodies for atherosclerosis-associated neo-antigens and apoptotic cells. J Immunol. 2003;170:6151\u20137.","journal-title":"J Immunol"},{"key":"9453_CR25","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1084\/jem.20031763","volume":"200","author":"MK Chang","year":"2004","unstructured":"Chang MK, Binder CJ, Miller YI, Subbanagounder G, Silverman GJ, Berliner JA, et al. Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J Exp Med. 2004;200:1359\u201370.","journal-title":"J Exp Med"},{"key":"9453_CR26","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1073\/pnas.96.11.6353","volume":"96","author":"MK Chang","year":"1999","unstructured":"Chang MK, Bergmark C, Laurila A, Horkko S, Han KH, Friedman P, et al. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc Natl Acad Sci USA. 1999;96:6353\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9453_CR27","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.atherosclerosis.2005.10.017","volume":"188","author":"J Su","year":"2006","unstructured":"Su J, Georgiades A, Wu R, Thulin T, de Faire U, Frostegard J. Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension. Atherosclerosis. 2006;188:160\u20136.","journal-title":"Atherosclerosis"},{"key":"9453_CR28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0896-8411(89)90107-8","volume":"2","author":"E Goshen","year":"1989","unstructured":"Goshen E, Livne A, Krupp M, Hammarstrom L, Dighiero G, Slor H, et al. Antinuclear and related autoantibodies in sera of healthy subjects with IgA deficiency. J Autoimmun. 1989;2:51\u201360.","journal-title":"J Autoimmun"},{"key":"9453_CR29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1399-3038.1997.tb00165.x","volume":"8","author":"M Hahn-Zoric","year":"1997","unstructured":"Hahn-Zoric M, Carlsson B, Bjorkander J, Mellander L, Friman V, Padyukov L, et al. Variable increases of IgG and IgM antibodies in milk of IgA deficient women. Pediatr Allergy Immunol. 1997;8:127\u201333.","journal-title":"Pediatr Allergy Immunol"},{"key":"9453_CR30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1006650812886","volume":"20","author":"R Albuquerque Campos de","year":"2000","unstructured":"de Albuquerque Campos R, Sato MN, da Silva Duarte AJ. IgG anti-IgA subclasses in common variable immunodeficiency and association with severe adverse reactions to intravenous immunoglobulin therapy. J Clin Immunol. 2000;20:77\u201382.","journal-title":"J Clin Immunol"},{"key":"9453_CR31","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.intimp.2007.04.011","volume":"7","author":"RM Mazzuco","year":"2007","unstructured":"Mazzuco RM, Sato MN, de Vasconcelos DM, Duarte AJ. Cross-reactivity of anti-phosphorylcholine antibodies to neuromuscular blockers in a murine model of immunization. Int Immunopharmacol. 2007;7:1170\u20138.","journal-title":"Int Immunopharmacol"},{"key":"9453_CR32","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.4049\/jimmunol.138.10.3325","volume":"138","author":"MG Scott","year":"1987","unstructured":"Scott MG, Briles DE, Shackelford PG, Smith DS, Nahm MH. Human antibodies to phosphocholine. IgG anti-PC antibodies express restricted numbers of V and C regions. J Immunol. 1987;138:3325\u201331.","journal-title":"J Immunol"},{"key":"9453_CR33","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1084\/jem.156.4.1177","volume":"156","author":"DE Briles","year":"1982","unstructured":"Briles DE, Forman C, Hudak S, Claflin JL. Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J Exp Med. 1982;156:1177\u201385.","journal-title":"J Exp Med"},{"key":"9453_CR34","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/341658","volume":"186","author":"JM Gould","year":"2002","unstructured":"Gould JM, Weiser JN. The inhibitory effect of C-reactive protein on bacterial phosphorylcholine platelet-activating factor receptor-mediated adherence is blocked by surfactant. J Infect Dis. 2002;186:361\u201371.","journal-title":"J Infect Dis"},{"key":"9453_CR35","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/rheumatology\/ken120","volume":"47","author":"J Su","year":"2008","unstructured":"Su J, Hua X, Concha H, Svenungsson E, Cederholm A, Frostegard J. Natural antibodies against phosphorylcholine as potential protective factors in SLE. Rheumatology. 2008;47:1144\u201350.","journal-title":"Rheumatology"},{"key":"9453_CR36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1196\/annals.1313.016","volume":"1050","author":"J Damoiseaux","year":"2005","unstructured":"Damoiseaux J, Jeyasekharan AD, Theunissen R, Tervaert JW. Cross-reactivity of IgM and IgG anticardiolipin antibodies with oxidized-low density lipoproteins. Ann NY Acad Sci. 2005;1050:163\u20139.","journal-title":"Ann NY Acad Sci"},{"key":"9453_CR37","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1191\/0961203304lu1088oa","volume":"13","author":"M Blank","year":"2004","unstructured":"Blank M, Shoenfeld Y. Antiphosphatidylserine antibodies and reproductive failure. Lupus. 2004;13:661\u20135.","journal-title":"Lupus"},{"key":"9453_CR38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/03009749509100875","volume":"24","author":"A Savolainen","year":"1995","unstructured":"Savolainen A, von Essen R, Leikola J, Alfthan G, Vaarala O, Palosuo T, et al. Antibodies against oxidised low-density lipoprotein in juvenile chronic arthritis. Scand J Rheumatol. 1995;24:209\u201311.","journal-title":"Scand J Rheumatol"},{"key":"9453_CR39","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","volume":"105","author":"P Libby","year":"2002","unstructured":"Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135\u201343.","journal-title":"Circulation"},{"key":"9453_CR40","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/nm1102-1218","volume":"8","author":"CJ Binder","year":"2002","unstructured":"Binder CJ, Chang MK, Shaw PX, Miller YI, Hartvigsen K, Dewan A, et al. Innate and acquired immunity in atherogenesis. Nat Med. 2002;8:1218\u201326.","journal-title":"Nat Med"},{"key":"9453_CR41","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0140-6736(68)90527-8","volume":"2","author":"GN Vyas","year":"1968","unstructured":"Vyas GN, Perkins HA, Fudenberg HH. Anaphylactoid transfusion reactions associated with anti-IgA. Lancet. 1968;2:312\u20135.","journal-title":"Lancet"},{"key":"9453_CR42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.21307\/immunohematology-2019-686","volume":"14","author":"R Munks","year":"1998","unstructured":"Munks R, Booth JR, Sokol RJ. A comprehensive IgA service provided by a blood transfusion center. Immunohematology. 1998;14:155\u201360.","journal-title":"Immunohematology"},{"key":"9453_CR43","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3109\/08916930903277329","volume":"43","author":"A Klartag","year":"2009","unstructured":"Klartag A, Chen CC, Dougherty JP, Ron Y. Cross-reactive antibodies induced by xenogeneic IgA can cause selective IgA deficiency. Autoimmunity. 2009;43:164\u201371.","journal-title":"Autoimmunity"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-010-9453-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-010-9453-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-010-9453-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T19:50:08Z","timestamp":1685735408000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-010-9453-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,25]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["9453"],"URL":"https:\/\/doi.org\/10.1007\/s10875-010-9453-y","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,25]]}}}